A Clinical Observation of Liver Fiber Mixture Combined with Adefovir Dipivoxil Capsules in Treatment of Qi-stagnancy and Blood Stasis Type Hepatitis with Hepatic Fibrosis
|更新时间:2024-01-04
|
A Clinical Observation of Liver Fiber Mixture Combined with Adefovir Dipivoxil Capsules in Treatment of Qi-stagnancy and Blood Stasis Type Hepatitis with Hepatic Fibrosis
Chinese Journal of Experimental Traditional Medical FormulaeVol. 20, Issue 9, Pages: 224-227(2014)
LIANG Bao-hui, LIN Juan, LIANG Jun-li, et al. A Clinical Observation of Liver Fiber Mixture Combined with Adefovir Dipivoxil Capsules in Treatment of Qi-stagnancy and Blood Stasis Type Hepatitis with Hepatic Fibrosis[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(9): 224-227.
DOI:
LIANG Bao-hui, LIN Juan, LIANG Jun-li, et al. A Clinical Observation of Liver Fiber Mixture Combined with Adefovir Dipivoxil Capsules in Treatment of Qi-stagnancy and Blood Stasis Type Hepatitis with Hepatic Fibrosis[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(9): 224-227. DOI: 10.11653/syfj2014090224.
A Clinical Observation of Liver Fiber Mixture Combined with Adefovir Dipivoxil Capsules in Treatment of Qi-stagnancy and Blood Stasis Type Hepatitis with Hepatic Fibrosis
Objective: Explore soft liver chemical fiber mixture joint adefovir capsule on the clinical effect of qi-stagnancy and blood stasis type liver fibrosis. Method: The treatment group 82 examples using soft liver chemical fiber mixture joint adefovir capsule treatment; the control group 82 patients taking adefovir capsule and other conventional protect liver drugs. After 12 months observation serum immunology and the ultrasonic index index. Result: After treatment
the treatment group patients with liver function index
liver fibrosis indexes and ultrasonics index significantly lower than the control group
the difference was statistically significant. Conclusion: Soft liver fiber mixture combined with adefovir dipivoxil capsules can improve liver fibrosis and ultrasonic liver function
qi-stagnancy and blood stasis type hepatitis B liver fibrosis indexes
Clinical Efficacy of Shugan Huazhuo Zhenyang Prescription in Treatment of Chronic Prostatitis Combined with Erectile Dysfunction
Clinical and Mechanism of Modified Xiaoyaosan and Its Effective Components in Treatment of Thyroid Diseases: A Review
Mechanism and Combination Therapy of Berberine in Treatment of Nonalcoholic Fatty liver Disease:A Review
Clinical Efficacy of Gandou Fumu Granules in Intervention of Liver Fibrosis in WD Patients with Phlegm and Blood Stasis Syndrome and Effect on Cuproptosis-related Indicators
Gandouling Regulates PI3K/Akt/mTOR Autophagy Signaling Pathway via LncRNA H19 for Treatment of Wilson Disease Liver Fibrosis
Related Author
YAN Zuzhen
ZHAO Zongjiang
LI Shanshan
FU Yu
WEI Dandan
WANG Fei
XU Mengjiao
WANG Ting
Related Institution
Beijing Chaoyang Jinzhan Second Community Health Service Center
Beijing University of Chinese Medicine
First Affiliated Hospital of Henan University of Chinese Medicine
The First Clinical Medical College of Henan University of Chinese Medicine
The First Affiliated Hospital of Henan University of Chinese Medicine